KOC
Koss-Olinger Consulting’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.09M | Buy |
3,300,000
+300,000
| +10% | +$372K | 0.34% | 42 |
|
|
2025
Q1 | $3.54M | Buy |
3,000,000
+1,000,000
| +50% | +$1.18M | 0.3% | 41 |
|
|
2024
Q4 | $3.66M | Buy |
2,000,000
+1,200,000
| +150% | +$2.2M | 0.32% | 41 |
|
|
2024
Q3 | $1.36M | Hold |
800,000
| – | – | 0.12% | 93 |
|
|
2024
Q2 | $1.1M | Buy |
+800,000
| New | +$1.1M | 0.1% | 96 |
|
|
2024
Q1 | – | Sell |
-100,000
| Closed | -$981K | – | 220 |
|
|
2023
Q4 | $981K | Buy |
+100,000
| New | +$981K | 0.1% | 99 |
|
|
2023
Q3 | – | Sell |
-60,000
| Closed | -$798K | – | 298 |
|
|
2023
Q2 | $798K | Hold |
60,000
| – | – | 0.09% | 105 |
|
|
2023
Q1 | $695K | Buy |
+60,000
| New | +$695K | 0.09% | 112 |
|
|
2021
Q3 | – | Sell |
-15,000
| Closed | -$525K | – | 263 |
|
|
2021
Q2 | $525K | Hold |
15,000
| – | – | 0.08% | 131 |
|
|
2021
Q1 | $500K | Buy |
+15,000
| New | +$500K | 0.09% | 126 |
|